Dahuya, Juman B.

HRN: 21-81-07  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/12/2022
CEFTRIAXONE 1G (VIAL)
08/12/2022
08/18/2022
IVT
2gms
Q24
Cap Mr
Waiting Final Action 
08/12/2022
AZITHROMYCIN 500MG TABLET (TAB)
08/12/2022
08/16/2022
PO
500mg
Q24
Cap Mr
Waiting Final Action 
08/13/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/13/2022
08/20/2022
IV
500mg
Q8
Acute Appendicitis
Waiting Final Action 
08/18/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
08/18/2022
08/24/2022
IV
4.5g
Qid
Typhoid; AGE; (immunocompromised)
Waiting Final Action 
08/18/2022
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
08/18/2022
08/23/2022
IV
400,000
TID
Candidasis; Immunocompromised
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: